Gordon P. Otto
Darmstadt, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: June 04, 2023
Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B.
Journal: Cell reports. Medicine
Published: October 05, 2022
Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management.
Journal: Clinical lung cancer
Published: December 16, 2021
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 27, 2021
A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US- and EU-reference biologics.
Journal: British journal of clinical pharmacology
Published: August 13, 2019
Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies.
Journal: Future oncology (London, England)
Published: March 06, 2019
Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching.
Journal: Critical care medicine
Published: August 12, 2017
Clinical Chemistry Reference Intervals for C57BL/6J, C57BL/6N, and C3HeB/FeJ Mice (Mus musculus).
Journal: Journal of the American Association for Laboratory Animal Science : JAALAS
Published: July 17, 2016
Acid Sphingomyelinase Promotes Endothelial Stress Response in Systemic Inflammation and Sepsis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: May 26, 2016
Criticizing reporting standards fails to improve quality in animal research.
Journal: Critical care (London, England)
Published: July 17, 2014
Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation.
Journal: Critical care (London, England)
Published: June 10, 2014
Last Updated: 09/26/2026